In the last decade, advances in molecular techniques have demonstrated recurrent genetic alterations in some salivary gland tumors, including the fusion of genes such as ETV6 in secretory carcinoma, MYB and MYBL1 in adenoid cystic carcinoma, and MAML2 in MEC (26–28). This evidence concerns the gene MYBL1 and adenoid cystic carcinoma.